![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.00 | 13.00 | 35.00 | 24.00 | 24.00 | 24.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.59 | 35.84M |
RNS Number:2403F Cambridge Antibody Tech Group PLC 27 June 2006 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 2. Name of shareholder having a major interest DEUTSCHE BANK AG 3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 DEUTSCHE BANK AG NOT NOTIFIED 4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them DEUTSCHE BANK AG NOT DISCLOSED 5. Number of shares / amount of stock acquired NOT DISCLOSED 6. Percentage of issued class N/A 7. Number of shares / amount of stock disposed NOT DISCLOSED 8. Percentage of issued class N/A 9. Class of security ORDINARY 10 PENCE SHARES 10. Date of transaction NOT DISCLOSED 11. Date company informed 27 JUNE 2006 12. Total holding following this notification NOT DISCLOSED 13. Total percentage holding of issued class following this notification NOT KNOWN 14. Any additional information DEUTSCHE BANK AG AND ITS SUBSIDIARY COMPANIES NO LONGER HAVE A NOTIFIABLE INTEREST IN THE ORDINARY SHARES OF CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC. 15. Name of contact and telephone number for queries JUSTIN HOSKINS 01223 898589 16. Name and signature of authorised company official responsible for making this notification JUSTIN HOSKINS, COMPANY SECRETARY Date of notification 27 JUNE 2006 The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material. This information is provided by RNS The company news service from the London Stock Exchange END HOLEALKXAALKEFE
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions